Last updated on March 2019

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis


Brief description of study

The purpose of this study is to evaluate the safety, tolerability, and efficacy of the combination of INCB050465 and ruxolitinib in subjects with myelofibrosis.

Clinical Study Identifier: NCT02718300

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )
If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service. ( Sign Up )